Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study
Part of paid clinical trials in San Diego, California.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT03998462
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Mindfulness Based Stress Reduction — BEHAVIORALMBSR used in this trial was based on the standard program developed by Jon Kabat-Zinn (1990). It consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour retreat during week 7. Due to the COVID-19 pandemic, the MBSR sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
- Psychoeducational Supportive Care — BEHAVIORALPSC is a novel intervention developed by Schiehser and colleagues to provide psychoeducation about Parkinson's disease and supportive group care. PSC consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour "retreat" during week 7. Due to the COVID-19 pandemic, all sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Study Details
To investigate the efficacy of Mindfulness-based Stress Reduction (MBSR) to improve quality of life, cognition, and mood, as well as to determine the longevity of the treatment response in individuals with Parkinson's disease (PD).
Key Dates
- Start date
- Jan 1, 2020
- Status verified
- Nov 2025
- Primary completion
- Nov 1, 2024
- Completion
- Nov 1, 2024
Study Design
- Enrollment
- 107 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Mindfulness Based Stress Reduction (MBSR)Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. The MBSR intervention was based on the standard program developed by Jon Kabat-Zinn (1990). It consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour retreat during week 7. Due to the COVID-19 pandemic, all MBSR sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
- Active Comparator: Psychoeducational Supportive Care (PSC)Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. PSC is a novel intervention developed by Schiehser and colleagues to serve as a control for MBSR in this trial. PSC was modeled after common support/education groups that provide support and psychoeducation about Parkinson's disease available in the community. PSC consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour "retreat" during week 7. Due to the COVID-19 pandemic, all sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Primary Outcome Measure
Parkinson's Disease Questionnaire-39 [ Time Frame: pre- to post-intervention (0 to 9 weeks) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA San Diego Healthcare System | San Diego | California | 92161-0002 | - |
Find similar trials in San Diego, CA
By condition
By specialty
By research site
Related Studies
- Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS RegistryRecruiting · Boston Scientific Corporation · Aliso Viejo, California
- Parkinson's Foundation PD GENEration Genetic RegistryRecruiting · Parkinson's Foundation · Birmingham, Alabama
- Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's DiseaseRecruiting · Helen M. Bronte-Stewart · Stanford, California
- Ketamine for Veterans With Parkinson's DiseasePHASE2 · Recruiting · VA Office of Research and Development · San Francisco, California